Naser L. Rezk
About
Naser L. Rezk is a scholar working on Infectious Diseases, Virology and Epidemiology.
According to data from OpenAlex, Naser L. Rezk has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 19 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Naser L. Rezk's work include HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (19 papers) and HIV/AIDS Research and Interventions (12 papers). Naser L. Rezk is often cited by papers focused on HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (19 papers) and HIV/AIDS Research and Interventions (12 papers). Naser L. Rezk collaborates with scholars based in United States, Saudi Arabia and United Kingdom. Naser L. Rezk's co-authors include Angela D. M. Kashuba, Amanda Corbett, Richard R. Tidwell, Arlene S. Bridges, Rosa F. Yeh, Rustin D. Crutchley, Kristine B. Patterson, Byung Hwa Jung, Myron S. Cohen and Nicole White and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
In The Last Decade
Naser L. Rezk
34 papers receiving 1.5k citations
Peers
Naser L. Rezk
Mauro Sciandra Italy
Marco Simiele Italy
Anne‐Marie Taburet France
Lorena Baietto Italy
Laura Else United Kingdom
Joseph E. Rower United States
Jessica Cusato Italy
Caroline Solas France
John Tjia United Kingdom
Robin DiFrancesco United States
Citations per year, relative to Naser L. Rezk Naser L. Rezk (= 1×)
peers
Mauro Sciandra
Countries citing papers authored by Naser L. Rezk
Since
Specialization
Citations
This map shows the geographic impact of Naser L. Rezk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naser L. Rezk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naser L. Rezk more than expected).
Fields of papers citing papers by Naser L. Rezk
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Naser L. Rezk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naser L. Rezk. The network helps show where Naser L. Rezk may publish in the future.
Co-authorship network of co-authors of Naser L. Rezk
This figure shows the co-authorship network connecting the top 25 collaborators of Naser L. Rezk. A scholar is included among the top collaborators of Naser L. Rezk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naser L. Rezk. Naser L. Rezk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Alı̀, Anna, et al.. (2015). Perception and attitude of physicians toward local generic medicines in Saudi Arabia: A questionnaire-based study. Saudi Pharmaceutical Journal. 23(4). 397–404.
2.
Rezk, Naser L., et al.. (2015). Pharmacist, the pharmaceutical industry and pharmacy education in Saudi Arabia: A questionnaire-based study. Saudi Pharmaceutical Journal. 23(5). 573–580.
3.
Iqbal, Muzaffar, Essam Ezzeldin, Khalid A. Al‐Rashood, Yousif A. Asiri, & Naser L. Rezk. (2014). Rapid determination of canagliflozin in rat plasma by UHPLC–MS/MS using negative ionization mode to avoid adduct-ions formation. Talanta. 132. 29–36.
4.
Rezk, Naser L.. (2013). Saudi pharmaceutical market: Current, future and R&D.
5.
Rezk, Naser L.. (2013). Innovation in method development; Drugs solubility and stability during bioanalysis process. Journal of Bioequivalence & Bioavailability.
6.
Kwara, Awewura, Margaret Lartey, Isaac Boamah, et al.. (2009). Interindividual Variability in Pharmacokinetics of Generic Nucleoside Reverse Transcriptase Inhibitors in TB/HIV‐Coinfected Ghanaian Patients:UGT2B7*1c Is Associated With Faster Zidovudine Clearance and Glucuronidation. The Journal of Clinical Pharmacology. 49(9). 1079–1090.
7.
Rezk, Naser L., Arlene S. Bridges, Amanda Corbett, et al.. (2009). Plasma Bile Acid Concentrations in Patients with Human Immunodeficiency Virus Infection Receiving Protease Inhibitor Therapy: Possible Implications for Hepatotoxicity. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(1). 17–24.
8.
Rezk, Naser L., et al.. (2009). A novel LC–ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma. Talanta. 79(5). 1372–1378.
9.
Leger, Paul, Rebecca Dillingham, Angela D. M. Kashuba, et al.. (2009). CYP2B6Variants and Plasma Efavirenz Concentrations during Antiretroviral Therapy in Port‐au‐Prince, Haiti. The Journal of Infectious Diseases. 200(6). 955–964.
10.
Cranage, Martin, Sally Sharpe, Carolina Herrera, et al.. (2008). Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir Gel. PLoS Medicine. 5(8). e157–e157.
11.
Rezk, Naser L., Nicole White, & Angela D. M. Kashuba. (2008). An accurate and precise high-performance liquid chromatography method for the rapid quantification of the novel HIV integrase inhibitor raltegravir in human blood plasma after solid phase extraction. Analytica Chimica Acta. 628(2). 204–213.
12.
Rezk, Naser L., Nicole White, Arlene S. Bridges, et al.. (2008). Studies on Antiretroviral Drug Concentrations in Breast Milk: Validation of a Liquid Chromatography-Tandem Mass Spectrometric Method for the Determination of 7 Anti-Human Immunodeficiency Virus Medications. Therapeutic Drug Monitoring. 30(5). 611–619.
13.
Jung, Byung Hwa, Naser L. Rezk, Arlene S. Bridges, Amanda Corbett, & Angela D. M. Kashuba. (2007). Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography–tandem mass spectrometry. Biomedical Chromatography. 21(10). 1095–1104.
14.
Dumond, Julie B., Rosa F. Yeh, Kristine B. Patterson, et al.. (2007). Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS. 21(14). 1899–1907.
15.
Rezk, Naser L., Rustin D. Crutchley, Rosa F. Yeh, & Angela D. M. Kashuba. (2006). Full Validation of an Analytical Method for the HIV-Protease Inhibitor Atazanavir in Combination With 8 Other Antiretroviral Agents and its Applicability to Therapeutic Drug Monitoring. Therapeutic Drug Monitoring. 28(4). 517–525.
16.
Yeh, Rosa F., Kristine B. Patterson, Naser L. Rezk, et al.. (2006). Lopinavir/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(1). 52–60.
17.
Corbett, Amanda, Joseph J. Eron, Susan A. Fiscus, Naser L. Rezk, & Angela D. M. Kashuba. (2004). The Pharmacokinetics, Safety, and Initial Virologic Response of a Triple???Protease Inhibitor Salvage Regimen Containing Amprenavir, Saquinavir, and Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(4). 921–928.
18.
Rezk, Naser L., Richard R. Tidwell, & Angela D. M. Kashuba. (2004). High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma. Journal of Chromatography B. 805(2). 241–247.
19.
Rezk, Naser L., Richard R. Tidwell, & Angela D. M. Kashuba. (2003). Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection. Journal of Chromatography B. 791(1-2). 137–147.
20.
Rezk, Naser L., Richard R. Tidwell, & Angela D. M. Kashuba. (2002). Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detection. Journal of Chromatography B. 774(1). 79–88.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mauro Sciandra Breakdown of academic impact, for papers by Marco Simiele Breakdown of academic impact, for papers by Anne‐Marie Taburet Breakdown of academic impact, for papers by Lorena Baietto Breakdown of academic impact, for papers by Laura Else Breakdown of academic impact, for papers by Joseph E. Rower Breakdown of academic impact, for papers by Jessica Cusato Breakdown of academic impact, for papers by Caroline Solas Breakdown of academic impact, for papers by John Tjia Breakdown of academic impact, for papers by Robin DiFrancesco